Sponsor pipeline

PAQ Therapeutics, Inc. clinical trial pipeline

Get alerts when PAQ Therapeutics, Inc.'s trials change

2 active trials 2 recruiting 4 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT06797336 A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors Solid Tumor Recruiting 2026-10-07
NCT07300150 A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors Colorectal Cancer Recruiting 2026-07-06

Disease areas by active trials

Colorectal Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Pancreatic Cancer (1)

Get alerts when PAQ Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free